Eisman, John A.
Cortet, Bernard
Boolell, Mitra
Ionescu-Ittu, Raluca
Vekeman, Francis
Heroux, Julie
Thomasius, Friederike
Funding for this research was provided by:
Theramex
Article History
Received: 22 June 2022
Accepted: 25 November 2022
First Online: 6 March 2023
Declarations
:
: Not applicable. Data are de-identified and comply with the Health Insurance Portability and Accountability Act (HIPAA) of 1996. Accordingly, this study did not require approval from an institutional review board or collection of inform consent.
: Not applicable.
: Not applicable.
: JAE had received research support and/or consultation fees from Amgen, MSD, Lilly, Theramex. BC has conducted occasional work (consultancies, advice, conferences, clinical studies, courses) for Alexion, Amgen, Aptissen, Expanscience, Ferring, Lilly, Kyowa-Kirin, MSD, Novartis, Theramex, UCB, and Viatris. MB is an employee of Theramex. RII and FV are employees of STATLOG, Inc., which have received research funding from Theramex for this study. JH is an employee of Héroux Consulting, Inc., which has received research funding from STATLOG for this study. FT has received fees for lectures and consultancy or investigator fees from Amgen, Gedeon Richter, Lilly, Hexal, Kyowa Kirin, Hologic, Novartis, Stada, Synexus, Theramex, and UCB.